CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
BiomStrip is developing a low-cost, non-invasive cancer screening device that functions like a pregnancy test. It detects changes in gut microbial flora to identify early signs of cancer, aiming to improve early diagnosis and treatment outcomes.
Cancer is the second leading cause of death globally, causing 1 in 6 deaths.
If cancer is diagnosed at early stage, it is highly likely to be treated successfully.
Once it has grown and spread, therapy is vastly more difficult and costly, and survival rate drops rapidly.
Screening is a vital healthcare element for early detection but suffers from burdens of cost, capacity, compliance, and detection sensitivity problems.BiomStrip introduces a pioneering screening solution that can carry out cance…
LOGODERM OKTATO ES SZOLGALTATO KORLATOLT FELELOSSEGU TARSASAG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
